In vivo protection of striatum from MPP+ neurotoxicity by N-methyl-d-aspartate antagonists

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

1985 • 1,236 citations

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

1984 • 772 citations

Pargyline Prevents MPTP-Induced Parkinsonism in Primates

1984 • 575 citations

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1991 • 554 citations

Scope and limitations of in vivo brain dialysis: A comparison of its application to various neurotransmitter systems

1987 • 431 citations

Excitatory amino acids and neuropsychiatrie disorders

1989 • 327 citations

Glutamatergic Control of Dopamine Release in the Rat Striatum: Evidence for Presynaptic N‐Methyl‐D‐Aspartate Receptors on Dopaminergic Nerve Terminals

1991 • 324 citations

ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, AND MOTONEURONE DISEASE: ABIOTROPIC INTERACTION BETWEEN AGEING AND ENVIRONMENT?

1986 • 257 citations

Presynaptic Glutamate Receptors Modulate Dopamine Release from Striatal Synaptosomes

1991 • 188 citations

Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP

1986 • 179 citations

Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes

1990 • 158 citations

MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study

1991 • 92 citations

The non-competitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenylpyridinium (MPP+)

1990 • 74 citations

Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.

1989 • 46 citations

Cited By (0)

Loading...